Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Lara C. Lacerda"'
Autor:
John V. Heymach, Jhanelle E. Gray, Vassiliki A. Papadimitrakopoulou, Jianjun Zhang, Bonnie S. Glisson, William N. William, J. Jack Lee, Stephen G. Swisher, Jack A. Roth, Jeff Lewis, Lara C. Lacerda, Yasir Elamin, Huiying Sun, Ming Tang, Waree Rinsurongkawong, Emily Roarty, Katherine L. Lovinger, J. Kevin Hicks, Theresa Boyle, Jacqulyne Robichaux, Monique B. Nilsson, Marcelo V. Negrao, Sonam Puri, Xiuning Le
Genetic profiling of 42 cases
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ef5431be9e66ad391ed6ed0fe267d34
https://doi.org/10.1158/1078-0432.22468565.v1
https://doi.org/10.1158/1078-0432.22468565.v1
Autor:
John V. Heymach, Jhanelle E. Gray, Vassiliki A. Papadimitrakopoulou, Jianjun Zhang, Bonnie S. Glisson, William N. William, J. Jack Lee, Stephen G. Swisher, Jack A. Roth, Jeff Lewis, Lara C. Lacerda, Yasir Elamin, Huiying Sun, Ming Tang, Waree Rinsurongkawong, Emily Roarty, Katherine L. Lovinger, J. Kevin Hicks, Theresa Boyle, Jacqulyne Robichaux, Monique B. Nilsson, Marcelo V. Negrao, Sonam Puri, Xiuning Le
Purpose:Osimertinib was initially approved for T790M-positive non–small cell lung cancer (NSCLC) and, more recently, for first-line treatment of EGFR-mutant NSCLC. However, resistance mechanisms to osimertinib have been incompletely described.Exper
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f6415d99f91051ff0ed5d92fa50b9be
https://doi.org/10.1158/1078-0432.c.6526994.v1
https://doi.org/10.1158/1078-0432.c.6526994.v1
Autor:
John V. Heymach, Jhanelle E. Gray, Vassiliki A. Papadimitrakopoulou, Jianjun Zhang, Bonnie S. Glisson, William N. William, J. Jack Lee, Stephen G. Swisher, Jack A. Roth, Jeff Lewis, Lara C. Lacerda, Yasir Elamin, Huiying Sun, Ming Tang, Waree Rinsurongkawong, Emily Roarty, Katherine L. Lovinger, J. Kevin Hicks, Theresa Boyle, Jacqulyne Robichaux, Monique B. Nilsson, Marcelo V. Negrao, Sonam Puri, Xiuning Le
Supplementary material methods figures and tables
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b118758671dfd80950cfce49789d891
https://doi.org/10.1158/1078-0432.22468568.v1
https://doi.org/10.1158/1078-0432.22468568.v1
Autor:
John V. Heymach, Jhanelle E. Gray, Vassiliki A. Papadimitrakopoulou, Jianjun Zhang, Bonnie S. Glisson, William N. William, J. Jack Lee, Stephen G. Swisher, Jack A. Roth, Jeff Lewis, Lara C. Lacerda, Yasir Elamin, Huiying Sun, Ming Tang, Waree Rinsurongkawong, Emily Roarty, Katherine L. Lovinger, J. Kevin Hicks, Theresa Boyle, Jacqulyne Robichaux, Monique B. Nilsson, Marcelo V. Negrao, Sonam Puri, Xiuning Le
Platform-match 18 cases
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cb642df1fd1384ec57e008da036d2a2
https://doi.org/10.1158/1078-0432.22468562.v1
https://doi.org/10.1158/1078-0432.22468562.v1
Autor:
Xiuning, Le, Sonam, Puri, Marcelo V, Negrao, Monique B, Nilsson, Jacqulyne, Robichaux, Theresa, Boyle, J Kevin, Hicks, Katherine L, Lovinger, Emily, Roarty, Waree, Rinsurongkawong, Ming, Tang, Huiying, Sun, Yasir, Elamin, Lara C, Lacerda, Jeff, Lewis, Jack A, Roth, Stephen G, Swisher, J Jack, Lee, William N, William, Bonnie S, Glisson, Jianjun, Zhang, Vassiliki A, Papadimitrakopoulou, Jhanelle E, Gray, John V, Heymach
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 24(24)
Osimertinib was initially approved for T790M-positive non-small cell lung cancer (NSCLC) and, more recently, for first-line treatment ofUsing cohorts from The University of Texas MD Anderson Lung Cancer Moonshot GEMINI and Moffitt Cancer Center lung